OptimizeRx Income Statement (2010-2026) | OPRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	13.63M	16.12M	20.31M	13.73M	13.98M	15.09M	19.65M	13.00M	13.82M	16.33M	28.37M	19.69M	18.81M	21.31M	32.32M	21.93M	29.20M	26.07M	32.24M	19.84M
Cost of Revenue (Quarter)	5.58M	7.05M	7.92M	5.63M	4.99M	5.66M	7.20M	5.57M	5.99M	6.53M	10.53M	7.49M	7.11M	7.86M	10.29M	8.58M	10.56M	8.55M	8.14M	4.73M
Gross Profit (Quarter)	8.04M	9.08M	12.39M	8.10M	8.99M	9.42M	12.45M	7.43M	7.83M	9.80M	17.84M	12.20M	11.70M	13.45M	22.02M	13.34M	18.64M	17.52M	24.10M	15.12M
Operating items
Selling, General & Administrative (Quarter)																				3.51M
Research & Development (Quarter)																3.25M				3.40M
Other Operating Expenses (Quarter)																				12.53M
Operating Expenses (Quarter)																				19.45M
Operating Income (Quarter)																				0.40M
EBIT (Quarter)																				0.40M
Non-operating items
Interest & Investment Income (Quarter)																				0.08M
Other Non Operating Income (Quarter)																				0.04M
Non Operating Income (Quarter)																				-1.04M
Net income details
EBT (Quarter)																				-0.64M
Tax Provisions (Quarter)																				-0.15M
Profit After Tax (Quarter)																				-0.49M
Income from Non-Controlling Interests (Quarter)	0.35M	0.04M		-3.76M	-3.88M	-3.47M		-6.40M	-4.16M
Income from Continuing Operations (Quarter)																				-0.49M
Consolidated Net Income (Quarter)																				-0.49M
Income towards Parent Company (Quarter)																				-0.49M
Net Income towards Common Stockholders (Quarter)																				-0.49M
Additional items
EPS (Basic) (Quarter)																				-0.03
EPS (Weighted Average and Diluted) (Quarter)																				-0.03
Shares Outstanding (Weighted Average) (Quarter)																				18.76M
Shares Outstanding (Diluted Average) (Quarter)																				18.76M
EBITDA (Quarter)																				0.40M
Interest Expenses (Quarter)																				1.16M
Tax Rate (Quarter)																				23.14%

Research Tools

OptimizeRx Income Statement (2010-2026) | OPRX

Create an account

Sign In

Reset Password